AI-Integrated Cardiac Sensing and Therapy System

The invention integrates AI, IoT, blockchain, and new materials to create a more powerful cardiac sensing and therapy system that adapts to a patient's heart position state and provides personalized therapy recommendations.

The original patent disclosed a method for controlling delivery of anti-tachyarrhythmia shock therapy by a medical device system. However, it did not account for the patient's heart position state, leading to suboptimal therapy delivery. The new inventive concept addresses this limitation by integrating AI, IoT, blockchain, and new materials to provide a more comprehensive and personalized cardiac sensing and therapy system.

The AI-Integrated Cardiac Sensing and Therapy System comprises a medical device system, an AI-powered analytics module, an IoT-enabled sensor network, a blockchain-based data storage system, and a new material-based implantable medical device. The medical device system determines the patient's heart position state and modifies at least one cardiac therapy or sensing parameter value accordingly. The AI-powered analytics module analyzes patient data and provides personalized therapy recommendations based on the modified parameter values. The IoT-enabled sensor network monitors patient activity and environmental factors, while the blockchain-based data storage system securely stores and shares patient data. The new material-based implantable medical device enhances therapy delivery. The system transmits the modified parameter value to a remote server for storage and analysis, receiving feedback to adjust the modified parameter value.

The new claims introduce the integration of AI, IoT, blockchain, and new materials to create a more powerful cardiac sensing and therapy system that adapts to a patient's heart position state. This integration provides a non-obvious solution to the problem of suboptimal therapy delivery, as it enables personalized therapy recommendations and real-time data analysis.

Alternative embodiments of the inventive concept could include integrating other distinct technologies, such as machine learning algorithms or cloud-based data storage. Variations could include using different types of sensors or implantable medical devices.

The AI-Integrated Cardiac Sensing and Therapy System has significant commercial potential in the medical device industry, particularly in the areas of cardiac pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices. The system's ability to provide personalized therapy recommendations and real-time data analysis makes it an attractive solution for healthcare providers and patients.